세계의 여성 건강 시장 리포트(2023년)

“Women's Health Global Market Report 2023 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on women's health market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for women's health? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The women's health market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

• 1) By Product Type: Devices; Drugs; Pharmaceutical Pipeline

• 2) By Age: 50 Years & above; Other Ages

• 3) By Treatment Type: Hormonal Treatment; Non-Hormonal Treatment; Surgeries

• 4) By Application: Postmenopausal Osteoporosis; Hormonal Infertility; Endometriosis & Uterine Fibroids; Contraceptives; Menopause; Polycystic Ovary Syndrome (PCOS)

• 5) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies

• Companies Mentioned: AbbVie Inc.; Bayer AG; Merck & Co Inc.; Pfizer Inc.; Agile Therapeutics

• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

• Time series: Five years historic and ten years forecast.

• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

• Delivery Format: PDF, Word and Excel Data Dashboard.

Executive Summary

Major players in the women's health market are: AbbVie Inc., Bayer AG, Merck & Co Inc., Pfizer Inc., Agile Therapeutics, Amgen Inc., Apothecus Pharmaceutical Corporation, Blairex Laboratories Inc., Novartis AG, AstraZeneca plc, F. Hoffmann-La Roche Ltd., Ferring Pharmaceuticals, Lupin Pharmaceuticals Inc., Johnson & Johnson Services Inc., Allergan Plc, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Siemens AG, and Hologic Inc.

The global women's health market is expected to grow from $39.43 billion in 2022 to $41.40 billion in 2023 at a compound annual growth rate (CAGR) of 5.0%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The women's health market is expected to grow to $49.86 billion in 2027 at a CAGR of 4.8%.

The women's health market consists of revenues earned by entities by providing hormone therapy, birth control treatment, and other related services. The market value includes the value of related goods sold by the service provider or included within the service offering. The women's health market also includes sales of contraceptive devices and pharmaceuticals, densitometry, breast implants, obstetrics or gynaecology biopsy, imaging devices, and drugs such as Xgeva, Evista, Mirena, Zometa, Reclast, and class, and other types which are used in providing women's health services. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

Women's health is the area of medicine that focuses on the identification and management of ailments and illnesses that have an impact on a woman's physical and psychological health.

North America was the largest region in the women's health market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the women's health market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The main types of products for women's health include devices, drugs, and pharmaceutical pipelines. Women's health devices are the devices that are used to cure medical diseases of women. Women aged 50 years and above, and others undergo hormonal treatment, non-hormonal treatment, and surgeries for various applications including postmenopausal osteoporosis, hormonal infertility, endometriosis, uterine fibroids, contraceptives, menopause, polycystic ovary syndrome (PCOS) through various distribution channels such as hospital, retail, and online pharmacies.

The rising prevalence of women-centric diseases is expected to propel the growth of the women's health market going forward. The women-centric diseases such as anemia, osteoporosis, breast cancer, menopause, and others are highly occurring due to various risk factors such as family history, increasing age, early onset of periods or menopause after 55 years, obesity, and others. This rising prevalence of women-centric diseases drives demand for women's health products and services that are required to treat these diseases and ensure the health and wellness of women. For instance, the World Health Organization (WHO), a specialized institution based in Switzerland responsible for global public health, estimates that in 2020, 2.3 million women received a breast cancer diagnosis, and there will be 685,000 fatalities worldwide. Breast cancer was the world's most prevalent cancer as there were 7.8 million women diagnosed with breast cancer living in the past 5 years. Therefore, the rising prevalence of women-centric diseases is driving the growth of the women's health market.

Developments in women's health are a key trend in the women's health market. Major companies operating in the women's health market are developing new products to strengthen their position. For instance, in November 2021, FemTec Health, a US-based startup that focuses on women's health and beauty using technology and data to personalize care, developed a data analytics platform and infrastructure called BiomeAI to customize care by using genetic, consumer, microbiome, and biometric data. The BiomeAI engine uses deep machine learning and AI to translate this data into the delivery of holistic healthcare personalized for every woman.

In May 2021, Partners Group, a Switzerland-based global private equity firm acquired Axia Women's Health for aan undisclosed amount. With this acquisition, Partners Group added one more growing portfolio to its North American healthcare businesses. Axia Women's Health is a US-based women's healthcare services firm operating in the women's health market.

The countries covered in the women's health market report are: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The women's health market research report is one of a series of new reports from The Business Research Company that provides women's health market statistics, including women's health industry global market size, regional shares, competitors with a women's health market share, detailed women's health market segments, market trends and opportunities, and any further data you may need to thrive in the women's health industry. This women's health market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Table of Contents

1. Executive Summary

2. Women's Health Market Characteristics

3. Women's Health Market Trends And Strategies

4. Women's Health Market - Macro Economic Scenario

• 4.1. COVID-19 Impact On Women's Health Market
• 4.2. Ukraine-Russia War Impact On Women's Health Market
• 4.3. Impact Of High Inflation On Women's Health Market

5. Women's Health Market Size And Growth

• 5.1. Global Women's Health Historic Market, 2017-2022, $ Billion
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints On The Market
• 5.2. Global Women's Health Forecast Market, 2022-2027F, 2032F, $ Billion
  • 5.2.1. Drivers Of The Market
  • 5.2.2. Restraints On the Market

6. Women's Health Market Segmentation

• 6.1. Global Women's Health Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• Devices
• Drugs
• Pharmaceutical Pipeline
• 6.2. Global Women's Health Market, Segmentation By Age, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

50 Years and above

• Other Ages
• 6.3. Global Women's Health Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• Hormonal Treatment
• Non-Hormonal Treatment
• Surgeries
• 6.4. Global Women's Health Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• Postmenopausal Osteoporosis
• Hormonal Infertility
• Endometriosis & Uterine Fibroids
• Contraceptives
• Menopause
• Polycystic Ovary Syndrome (PCOS)
• 6.5. Global Women's Health Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

7. Women's Health Market Regional And Country Analysis

• 7.1. Global Women's Health Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 7.2. Global Women's Health Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

8. Asia-Pacific Women's Health Market

• 8.1. Asia-Pacific Women's Health Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Women's Health Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 8.3. Asia-Pacific Women's Health Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

9. China Women's Health Market

• 9.1. China Women's Health Market Overview
• 9.2. China Women's Health Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
• 9.3. China Women's Health Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

10. India Women's Health Market

• 10.1. India Women's Health Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 10.2. India Women's Health Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

11. Japan Women's Health Market

• 11.1. Japan Women's Health Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 11.2. Japan Women's Health Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

12. Australia Women's Health Market

• 12.1. Australia Women's Health Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 12.2. Australia Women's Health Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

13. Indonesia Women's Health Market

• 13.1. Indonesia Women's Health Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 13.2. Indonesia Women's Health Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

14. South Korea Women's Health Market

• 14.1. South Korea Women's Health Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 14.2. South Korea Women's Health Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

15. Western Europe Women's Health Market

• 15.1. Western Europe Women's Health Market Overview
• 15.2. Western Europe Women's Health Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 15.3. Western Europe Women's Health Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

16. UK Women's Health Market

• 16.1. UK Women's Health Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 16.2. UK Women's Health Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

17. Germany Women's Health Market

• 17.1. Germany Women's Health Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 17.2. Germany Women's Health Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

18. France Women's Health Market

• 18.1. France Women's Health Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 18.2. France Women's Health Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

19. Eastern Europe Women's Health Market

• 19.1. Eastern Europe Women's Health Market Overview
• 19.2. Eastern Europe Women's Health Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 19.3. Eastern Europe Women's Health Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

20. Russia Women's Health Market

• 20.1. Russia Women's Health Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 20.2. Russia Women's Health Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

21. North America Women's Health Market

• 21.1. North America Women's Health Market Overview
• 21.2. North America Women's Health Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 21.3. North America Women's Health Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

22. USA Women's Health Market

• 22.1. USA Women's Health Market Overview
• 22.2. USA Women's Health Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 22.3. USA Women's Health Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

23. South America Women's Health Market

• 23.1. South America Women's Health Market Overview
• 23.2. South America Women's Health Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 23.3. South America Women's Health Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

24. Brazil Women's Health Market

• 24.1. Brazil Women's Health Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 24.2. Brazil Women's Health Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

25. Middle East Women's Health Market

• 25.1. Middle East Women's Health Market Overview
• 25.2. Middle East Women's Health Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 25.3. Middle East Women's Health Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

26. Africa Women's Health Market

• 26.1. Africa Women's Health Market Overview
• 26.2. Africa Women's Health Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 26.3. Africa Women's Health Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

27. Women's Health Market Competitive Landscape And Company Profiles

• 27.1. Women's Health Market Competitive Landscape
• 27.2. Women's Health Market Company Profiles
  • 27.2.1. AbbVie Inc
    • 27.2.1.1. Overview
    • 27.2.1.2. Products and Services
    • 27.2.1.3. Strategy
    • 27.2.1.4. Financial Performance
  • 27.2.2. Bayer AG
    • 27.2.2.1. Overview
    • 27.2.2.2. Products and Services
    • 27.2.2.3. Strategy
    • 27.2.2.4. Financial Performance
  • 27.2.3. Merck & Co Inc
    • 27.2.3.1. Overview
    • 27.2.3.2. Products and Services
    • 27.2.3.3. Strategy
    • 27.2.3.4. Financial Performance
  • 27.2.4. Pfizer Inc
    • 27.2.4.1. Overview
    • 27.2.4.2. Products and Services
    • 27.2.4.3. Strategy
    • 27.2.4.4. Financial Performance
  • 27.2.5. Agile Therapeutics
    • 27.2.5.1. Overview
    • 27.2.5.2. Products and Services
    • 27.2.5.3. Strategy
    • 27.2.5.4. Financial Performance

28. Key Mergers And Acquisitions In The Women's Health Market

29. Women's Health Market Future Outlook and Potential Analysis

30. Appendix

• 30.1. Abbreviations
• 30.2. Currencies
• 30.3. Historic And Forecast Inflation Rates
• 30.4. Research Inquiries
• 30.5. The Business Research Company
• 30.6. Copyright And Disclaimer